Concomitantly, with AD-related signs of neurodegeneration, glutamate excitotoxicity-enhancing features appeared such as decreased Gad65 protein level and enzyme activity and decreased hippocampal expression of the glutamate-inhibitory NMDA receptor subtype, Grin3a (NR3A). Here, GAD2 is linked to Alzheimer disease.